Prostate biopsy: is age important for determining the pathological features in prostate cancer? (original) (raw)
Effect of Ageing on Morphologic and Clinical Predictors of Prostate Cancer Progression
Cheryl Yemoto
The Prostate Journal, 2000
View PDFchevron_right
Evaluation of an Aggressive Prostate Biopsy Strategy in Men Younger than 50 years of Age
Antonio Finelli
The Journal of urology, 2018
View PDFchevron_right
Is Age an Independent Factor for Prostate Cancer? A Paired Analysis
Jose da Cruz
Current Urology, 2017
View PDFchevron_right
Prostate biopsy in the elderly: histologic findings and treatment necessity
Hikmet köseoğlu
Asian Pacific journal of cancer prevention : APJCP, 2014
View PDFchevron_right
Age impact in clinicopathologic presentation and the clinical evolution of prostate cancer in patients submitted to radical prostatectomy
Katia Ramos Moreira Leite
International braz j urol, 2006
View PDFchevron_right
PROSTATE CANCER IN MEN AGE 50 YEARS OR YOUNGER
John Foley
The Journal of Urology, 2000
View PDFchevron_right
Evaluation of the pathologic results of prostate biopsies in terms of age, Gleason score and PSA level: Our experience and review of the literature
Ali Unsal
Archivio Italiano di Urologia e Andrologia, 2014
View PDFchevron_right
Prognostic values of morphological and clinical parameters in pT2-pT3 prostate cancer in elderly people
Dean Markic
Collegium antropologicum, 2010
View PDFchevron_right
Prostate Cancer in Younger and Older Patients: Do We Treat Them Differently?
Gerhard Situmorang
Asian Pacific Journal of Cancer Prevention, 2012
View PDFchevron_right
Does age influence the behaviour of localized prostate cancer?
Mary Gospodarowicz
BJU International, 2002
View PDFchevron_right
Carcinoma of the Prostate in Elderly Men: Incidence, Growth Characteristics and Clinical Significance
david mutchnik
Journal of Urology, 1969
View PDFchevron_right
Clinicopathological study of neoplastic and non-neoplastic lesions of prostate-two years study
IP Innovative Publication Pvt. Ltd.
IP Innovative Publication Pvt. Ltd., 2017
View PDFchevron_right
Retrospective and prospective study of prostate cancer for a period of five years
Rajashekar Reddy
Asian Pacific journal of health sciences, 2014
View PDFchevron_right
Characteristics of metastatic prostate cancer occurring in patients under 50 years of age
Jaime Montes
Actas Urológicas Españolas (English Edition), 2010
View PDFchevron_right
Relationship of age to outcome and clinicopathologic findings in men submitted to radical prostatectomy
Ubirajara Ferreira
International braz j urol, 2005
View PDFchevron_right
Positive Prostate Biopsy Rate Consistently Increases with Age at the Same Prostate-Specific Antigen Level in Patients with Normal Digital Rectal Examination
Roberto Orozco
Urology, 1998
View PDFchevron_right
Prostate cancer in the elderly
Dragan Golijanin
Cancer, 2012
View PDFchevron_right
Observations on Pathology Trends in 62,537 Prostate Biopsies Obtained from Urology Private Practices in the United States
Roberto Orozco
Urology, 1998
View PDFchevron_right
Incidental Prostate cancer in TURP specimens in men up to 65 years of age
Damien Bolton
Prostate International, 2015
View PDFchevron_right
Relationship between Prostate Specific Antigen, Prostate Volume and Age in the Benign Prostate
Daniel Moreira
British Journal of Urology, 1993
View PDFchevron_right
Neoplastic and Borderline Lesions of the Prostate.: Autopsy Study and Epidemiological Data
Furio Silvestri
Pathology - Research and Practice, 1995
View PDFchevron_right
Men under the age of 55 years with screen detected prostate cancer do not have less significant disease compared to older men in a population of patients in Australia
Tania Hossack
BMC Urology, 2015
View PDFchevron_right
PRECANCEROUS LESIONS OF PROSTATE A CLINICO-PATHOLOGICAL STUDY
IJAR Indexing
View PDFchevron_right
Histopathological study of prostatic lesions in correlation with serum prostate specific antigen levels in elderly men
ravindra karle
International Journal of Research in Medical Sciences, 2020
View PDFchevron_right
Elderly and Prostate Cancer Screening
Konstantinos Stamatiou
View PDFchevron_right
Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. prostate specific antigen
Hans Lilja
The Journal of …, 1998
View PDFchevron_right
Temporal changes in the pathologic assessment of prostate cancer
Scott Lucia
Journal of the National Cancer Institute. Monographs, 2012
View PDFchevron_right
Prostate Cancer: Is It a Battle Lost to Age?
radha pallati
Geriatrics, 2016
View PDFchevron_right
Prostate cancer: pathophysiology, diagnosis, and prognosis
falah salih
2016
View PDFchevron_right
Most prostate cancers missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significant
Roberto Orozco
1998
View PDFchevron_right